| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 08/30/2006 | EP0910643B1 Ribonuclease resistant rna preparation and utilization |
| 08/30/2006 | CN1826414A Mutant adeno-associated virus virions and methods of use thereof |
| 08/30/2006 | CN1826409A Synthetic gene encoding human epidermal growth factor 2/NEU antigen and uses thereof |
| 08/30/2006 | CN1826407A High titer recombinant influenza viruses for vaccines and gene therapy |
| 08/30/2006 | CN1826406A Production of poxviruses with adherent or non adherent avian cell lines |
| 08/30/2006 | CN1272440C Use and constructing method for anticancer recombined gland virus with tumor cell PLK1 as target of medicine |
| 08/29/2006 | US7098323 Polynucleotide squences and amino acid sequences for diagnosis of diseases and growth factors |
| 08/29/2006 | US7098313 DNA sequences coding for a polyol carrier and their use, in particular for the preparation of transgenic plants |
| 08/29/2006 | US7097842 Modified vaccinia virus ankara for the vaccination of neonates |
| 08/24/2006 | WO2006088229A1 Modified virus capsid protein and the use thereof |
| 08/24/2006 | WO2006069413A3 Method for isolating cells and viruses |
| 08/24/2006 | WO2006060314A9 Generation of replication competent viruses for therapeutic use |
| 08/24/2006 | US20060188991 Flexible vaccine assembly and vaccine delivery platform |
| 08/24/2006 | US20060188977 Non-tumorigenic MDCK cell line for propagating viruses |
| 08/24/2006 | US20060188872 Novel post-transcriptional regulatory elements and uses thereof |
| 08/24/2006 | US20060188522 Viral agents |
| 08/24/2006 | US20060188484 Virus vectors and methods of making and administering the same |
| 08/24/2006 | US20060188483 Virus vectors and methods of making and administering the same |
| 08/24/2006 | US20060188480 Viral vectors |
| 08/24/2006 | US20060188479 Plasmid for tissue targeted treatment of tumors; antitumor agents |
| 08/24/2006 | DE4192786B4 Masernvirus-Rekombinanter Pockenvirus-Impfstoff Measles virus recombinant poxvirus vaccine |
| 08/24/2006 | DE102005006388A1 Replikationsdefiziente RNA-Viren als Impfstoffe Replication-deficient RNA viruses as vaccines |
| 08/23/2006 | EP1693459A1 Chimeric type 5/type 11 or type 35 adenovirus vector for preventing infection with antihuman immunodeficiency virus |
| 08/23/2006 | EP1692294A2 Vectors, mutant viruses and methods for generating mutant viruses |
| 08/23/2006 | EP1692280A1 Method of producing baculovirus |
| 08/23/2006 | EP1692279A2 Preservative-containing virus formulations |
| 08/23/2006 | EP1692278A1 Hbv variants detection and application |
| 08/23/2006 | EP1692277A1 Methods and kits for predicting an infectious disease state |
| 08/23/2006 | CN1821410A Recombinant adenovirus containing codon optimized type IIPV16L1 gene |
| 08/22/2006 | US7094868 Peptides for recognition and targeting of GLIAL cell tumors |
| 08/22/2006 | US7094412 Poxvirus containing formulations and process for preparing stable poxvirus containing compositions |
| 08/22/2006 | US7094411 Avirulent, immunogenic flavivirus chimeras |
| 08/22/2006 | US7094409 Antigen arrays for treatment of allergic eosinophilic diseases |
| 08/22/2006 | US7094399 Use of spliceosome mediated RNA trans-splicing to confer cell selective replication to adenoviruses |
| 08/17/2006 | WO2006085822A1 Site-specific immunization in order to establish antibodies with specificity for the e7 oncoprotein of high-risk hpvs |
| 08/17/2006 | WO2006085749A1 Plant virus designated tomato torrado virus |
| 08/17/2006 | WO2006085668A1 Magnetic composite body, production method thereof, method for removing substance with mannose on its surface, and method for concentrating substance with mannose on its surface |
| 08/17/2006 | WO2005049845A9 Oncolytic herpes simplex virus encoding a heterologous nitroreductase |
| 08/17/2006 | WO2005049814A3 Novel atypical pneumonia-causing virus |
| 08/17/2006 | WO2005021713A3 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
| 08/17/2006 | US20060183705 Immunoglobins; antibodies; immunogens; hepatitis b surface antigens |
| 08/17/2006 | US20060183699 Immunoglobins; antibodies; immunogens; hepatitis b surface antigens |
| 08/17/2006 | US20060183232 Packaging cells for recombinant adenovirus |
| 08/17/2006 | US20060183226 Methods for retrotransposing long interspersed elements (lines) |
| 08/17/2006 | US20060183224 Animal-free cell culture method |
| 08/17/2006 | US20060182764 Enhancing the effect of vaccines, particularly hepatitus B vaccines, by the use of ribavirin as an adjuvant; single administration |
| 08/17/2006 | US20060182762 Enterovirus, vaccines, medicaments and diagnostic kits |
| 08/17/2006 | CA2596621A1 Site-specific immunization in order to establish antibodies with specificity for the e7 oncoprotein of high-risk hpvs |
| 08/16/2006 | EP1691198A1 Method of detecting hepatitis c virus |
| 08/16/2006 | EP1690941A1 Papilloma virus capsomere vaccine formulations and methods of use |
| 08/16/2006 | EP1690940A1 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 08/16/2006 | EP1690868A1 Modification of virus tropism and host range by viral genome shuffling |
| 08/16/2006 | EP1689857A1 Compositions comprising fetal liver cells and methods useful for hcv infection |
| 08/16/2006 | EP1276853B1 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 08/16/2006 | EP1087941B1 Thiolesters and uses thereof |
| 08/16/2006 | EP0836484B1 In vitro packaging of adeno-associated virus dna |
| 08/16/2006 | EP0784690B1 Complementary adenoviral vector systems and cell lines |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1820020A SARS-coronavirus virus-like particles and methods of use |
| 08/16/2006 | CN1818054A Method and apparatus for destroying cell or virus |
| 08/15/2006 | US7091324 For diagnosis and therapy of HCV infection, including being useful in the identification of patients expected to benefit from certain therapeutic strategies |
| 08/15/2006 | US7091030 Composition for the preservation of viruses |
| 08/15/2006 | US7091029 Preparing adeno-associated viral vectors for gene therapeutic treatment of respiratory system disorders |
| 08/15/2006 | US7091028 Method for directed packaging of molecular substances in protein shells |
| 08/15/2006 | US7090981 Chicken anaemia viruses of low pathogenicity |
| 08/15/2006 | US7090854 Chicken anaemia viruses of low pathogenicity |
| 08/15/2006 | US7090852 Virion protein; induce immunology response; genetic engineered Dna |
| 08/15/2006 | US7090845 Diagnosis and treatment of hepatic disorders |
| 08/10/2006 | WO2006082958A1 Method of retrovirus storage |
| 08/10/2006 | WO2006066066A3 Chimeric vectors |
| 08/10/2006 | WO2006055331A3 Porcine reproductive and respiratory syndrome virus strains and compositions |
| 08/10/2006 | WO2006036879A3 Chimeric gb virus b (gbv-b) |
| 08/10/2006 | WO2006029632A3 Chimeric phage-derived particles, methods for their production and use |
| 08/10/2006 | WO2005121376A3 Hiv variants showing a novel resistance mechanism against protease inhibitors, diagnostic assays for detecting the variant, and methods for identifying drugs effective against the resistant variant |
| 08/10/2006 | WO2005101966B1 Lipid-extracted therapeutic vaccine and method of use |
| 08/10/2006 | US20060177862 Ribosome display |
| 08/10/2006 | US20060177819 genetic engineered polynucleotides comprising nucleotide sequences that code alphavirus replication recognition sequences, nonstructural proteins and heterologous polynucleotides; infectious, replication-defective alphavirus particles used for immunotherapy, treatment of cancer and gene delivery |
| 08/09/2006 | EP1688485A1 Culturing circular ssDNA viruses for the production of vaccines |
| 08/09/2006 | EP1687325A2 Novel sequences encoding hapatitis c virus glycoproteins |
| 08/09/2006 | EP0752004B1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
| 08/09/2006 | CN1816620A Methods and compositions for the production of adenoviral vectors |
| 08/09/2006 | CN1816619A Method for purifying virus |
| 08/09/2006 | CN1816618A Minus strand RNA viral vectors carrying a gene with altered hypermutable regions |
| 08/09/2006 | CN1814752A Blood-plasma virus killing apparatus |
| 08/09/2006 | CN1268747C Recombinant newcastle disease virus RNA expression systems and vaccines |
| 08/08/2006 | US7087226 Lysin-deficient bacteriophages having reduced immunogenicity |
| 08/03/2006 | WO2006045532A3 Virosome particles comprising antigens from influenza virus and hepatitis b virus |
| 08/03/2006 | WO2006017279A3 Methods and compositions related to identifying protein-protein interactions |
| 08/03/2006 | WO2005091753A3 Flexible vaccine assembly and vaccine delivery platform |
| 08/03/2006 | US20060172287 Murine calicivirus |
| 08/03/2006 | US20060171962 SARS vaccine |
| 08/03/2006 | US20060171955 Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv |
| 08/03/2006 | US20060171922 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 08/02/2006 | EP1686180A2 Method of purification of recombinant viral vectors containing a therapeutic gene |
| 08/02/2006 | EP1685376A2 Viral fibers |
| 08/02/2006 | EP1685254A2 Oncolytic herpes simplex virus encoding a heterologous nitroreductase |
| 08/02/2006 | EP1685243A2 Immortalized avian cell lines for virus production |
| 08/02/2006 | EP1685238A2 Hcv replicons containing ns5b from genotype 2b |
| 08/02/2006 | EP1440149B1 Use of an infectious and attenuated type ii bovine viral diarrhea virus clone to prevent foetal infection by type i bvdv |
| 08/02/2006 | EP1381675B1 Method for replicating the hepatitis c virus |